 | • レポートコード：MRC2312MG06920 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、68ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の骨&関節における再生医療市場規模と予測を収録しています。・世界の骨&関節における再生医療市場：売上、2018年-2023年、2024年-2029年 ・世界の骨&関節における再生医療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の骨&関節における再生医療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「同種骨治療」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 骨&関節における再生医療のグローバル主要企業は、Anika Therapeutics Inc.、 Arthrex Inc.、 Baxter International Inc.、 Bioventus、 Conmed Corp.、 Depuy Synthes Products Inc.、 Medtronic Plc、 Royal Biologics、 Seikagaku Corp.、 Smith & Nephew Plc、 Stryker Corp.、 Zimmer Biomet Holdings Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、骨&関節における再生医療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の骨&関節における再生医療市場：タイプ別、2018年-2023年、2024年-2029年 世界の骨&関節における再生医療市場：タイプ別市場シェア、2022年 ・同種骨治療、自家骨治療、移植骨代替療法、整形外科&関節疾患治療 世界の骨&関節における再生医療市場：用途別、2018年-2023年、2024年-2029年 世界の骨&関節における再生医療市場：用途別市場シェア、2022年 ・整形外科、形成外科、その他 世界の骨&関節における再生医療市場：地域・国別、2018年-2023年、2024年-2029年 世界の骨&関節における再生医療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における骨&関節における再生医療のグローバル売上、2018年-2023年 ・主要企業における骨&関節における再生医療のグローバル売上シェア、2022年 ・主要企業における骨&関節における再生医療のグローバル販売量、2018年-2023年 ・主要企業における骨&関節における再生医療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Anika Therapeutics Inc.、 Arthrex Inc.、 Baxter International Inc.、 Bioventus、 Conmed Corp.、 Depuy Synthes Products Inc.、 Medtronic Plc、 Royal Biologics、 Seikagaku Corp.、 Smith & Nephew Plc、 Stryker Corp.、 Zimmer Biomet Holdings Inc. ************************************************************* ・調査・分析レポートの概要 骨&関節における再生医療市場の定義 市場セグメント 世界の骨&関節における再生医療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の骨&関節における再生医療市場規模 世界の骨&関節における再生医療市場規模：2022年 VS 2029年 世界の骨&関節における再生医療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの骨&関節における再生医療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の骨&関節における再生医療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：同種骨治療、自家骨治療、移植骨代替療法、整形外科&関節疾患治療 骨&関節における再生医療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：整形外科、形成外科、その他 骨&関節における再生医療の用途別グローバル売上・予測 ・地域別市場分析 地域別骨&関節における再生医療市場規模 2022年と2029年 地域別骨&関節における再生医療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Anika Therapeutics Inc.、 Arthrex Inc.、 Baxter International Inc.、 Bioventus、 Conmed Corp.、 Depuy Synthes Products Inc.、 Medtronic Plc、 Royal Biologics、 Seikagaku Corp.、 Smith & Nephew Plc、 Stryker Corp.、 Zimmer Biomet Holdings Inc. ... |
This research report provides a comprehensive analysis of the Bone and Joint Regenerative Medicines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Bone and Joint Regenerative Medicines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Bone and Joint Regenerative Medicines, challenges faced by the industry, and potential opportunities for market players.
The global Bone and Joint Regenerative Medicines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Bone and Joint Regenerative Medicines market presents opportunities for various stakeholders, including Orthopedics, Plastic Surgery. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Bone and Joint Regenerative Medicines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Bone and Joint Regenerative Medicines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Bone and Joint Regenerative Medicines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Bone and Joint Regenerative Medicines market.
Market Overview: The report provides a comprehensive overview of the Bone and Joint Regenerative Medicines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Allogeneic Bone Therapy, Autologous Bone Therapy）, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Bone and Joint Regenerative Medicines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Bone and Joint Regenerative Medicines market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Bone and Joint Regenerative Medicines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Bone and Joint Regenerative Medicines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Bone and Joint Regenerative Medicines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Bone and Joint Regenerative Medicines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Bone and Joint Regenerative Medicines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Bone and Joint Regenerative Medicines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Bone and Joint Regenerative Medicines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Allogeneic Bone Therapy
Autologous Bone Therapy
Bone Graft Substitutes Therapy
Orthopedic and Joint Diseases Therapy
Market segment by Application
Orthopedics
Plastic Surgery
Other Medical Applications
Global Bone and Joint Regenerative Medicines Market Segment Percentages, By Region and Country, 2022 (%）
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Anika Therapeutics Inc.
Arthrex Inc.
Baxter International Inc.
Bioventus
Conmed Corp.
Depuy Synthes Products Inc.
Medtronic Plc
Royal Biologics
Seikagaku Corp.
Smith & Nephew Plc
Stryker Corp.
Zimmer Biomet Holdings Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bone and Joint Regenerative Medicines, market overview.
Chapter 2: Global Bone and Joint Regenerative Medicines market size in revenue.
Chapter 3: Detailed analysis of Bone and Joint Regenerative Medicines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bone and Joint Regenerative Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Bone and Joint Regenerative Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bone and Joint Regenerative Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bone and Joint Regenerative Medicines Overall Market Size
2.1 Global Bone and Joint Regenerative Medicines Market Size: 2022 VS 2029
2.2 Global Bone and Joint Regenerative Medicines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bone and Joint Regenerative Medicines Players in Global Market
3.2 Top Global Bone and Joint Regenerative Medicines Companies Ranked by Revenue
3.3 Global Bone and Joint Regenerative Medicines Revenue by Companies
3.4 Top 3 and Top 5 Bone and Joint Regenerative Medicines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bone and Joint Regenerative Medicines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bone and Joint Regenerative Medicines Players in Global Market
3.6.1 List of Global Tier 1 Bone and Joint Regenerative Medicines Companies
3.6.2 List of Global Tier 2 and Tier 3 Bone and Joint Regenerative Medicines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Bone and Joint Regenerative Medicines Market Size Markets, 2022 & 2029
4.1.2 Allogeneic Bone Therapy
4.1.3 Autologous Bone Therapy
4.1.4 Bone Graft Substitutes Therapy
4.1.5 Orthopedic and Joint Diseases Therapy
4.2 By Type – Global Bone and Joint Regenerative Medicines Revenue & Forecasts
4.2.1 By Type – Global Bone and Joint Regenerative Medicines Revenue, 2018-2023
4.2.2 By Type – Global Bone and Joint Regenerative Medicines Revenue, 2024-2029
4.2.3 By Type – Global Bone and Joint Regenerative Medicines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bone and Joint Regenerative Medicines Market Size, 2022 & 2029
5.1.2 Orthopedics
5.1.3 Plastic Surgery
5.1.4 Other Medical Applications
5.2 By Application – Global Bone and Joint Regenerative Medicines Revenue & Forecasts
5.2.1 By Application – Global Bone and Joint Regenerative Medicines Revenue, 2018-2023
5.2.2 By Application – Global Bone and Joint Regenerative Medicines Revenue, 2024-2029
5.2.3 By Application – Global Bone and Joint Regenerative Medicines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Bone and Joint Regenerative Medicines Market Size, 2022 & 2029
6.2 By Region – Global Bone and Joint Regenerative Medicines Revenue & Forecasts
6.2.1 By Region – Global Bone and Joint Regenerative Medicines Revenue, 2018-2023
6.2.2 By Region – Global Bone and Joint Regenerative Medicines Revenue, 2024-2029
6.2.3 By Region – Global Bone and Joint Regenerative Medicines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Bone and Joint Regenerative Medicines Revenue, 2018-2029
6.3.2 US Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.3.3 Canada Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.3.4 Mexico Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Bone and Joint Regenerative Medicines Revenue, 2018-2029
6.4.2 Germany Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.3 France Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.4 U.K. Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.5 Italy Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.6 Russia Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.7 Nordic Countries Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.4.8 Benelux Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Bone and Joint Regenerative Medicines Revenue, 2018-2029
6.5.2 China Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.5.3 Japan Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.5.4 South Korea Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.5.5 Southeast Asia Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.5.6 India Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Bone and Joint Regenerative Medicines Revenue, 2018-2029
6.6.2 Brazil Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.6.3 Argentina Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Bone and Joint Regenerative Medicines Revenue, 2018-2029
6.7.2 Turkey Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.7.3 Israel Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.7.4 Saudi Arabia Bone and Joint Regenerative Medicines Market Size, 2018-2029
6.7.5 UAE Bone and Joint Regenerative Medicines Market Size, 2018-2029
7 Bone and Joint Regenerative Medicines Companies Profiles
7.1 Anika Therapeutics Inc.
7.1.1 Anika Therapeutics Inc. Company Summary
7.1.2 Anika Therapeutics Inc. Business Overview
7.1.3 Anika Therapeutics Inc. Bone and Joint Regenerative Medicines Major Product Offerings
7.1.4 Anika Therapeutics Inc. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.1.5 Anika Therapeutics Inc. Key News & Latest Developments
7.2 Arthrex Inc.
7.2.1 Arthrex Inc. Company Summary
7.2.2 Arthrex Inc. Business Overview
7.2.3 Arthrex Inc. Bone and Joint Regenerative Medicines Major Product Offerings
7.2.4 Arthrex Inc. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.2.5 Arthrex Inc. Key News & Latest Developments
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Company Summary
7.3.2 Baxter International Inc. Business Overview
7.3.3 Baxter International Inc. Bone and Joint Regenerative Medicines Major Product Offerings
7.3.4 Baxter International Inc. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.3.5 Baxter International Inc. Key News & Latest Developments
7.4 Bioventus
7.4.1 Bioventus Company Summary
7.4.2 Bioventus Business Overview
7.4.3 Bioventus Bone and Joint Regenerative Medicines Major Product Offerings
7.4.4 Bioventus Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.4.5 Bioventus Key News & Latest Developments
7.5 Conmed Corp.
7.5.1 Conmed Corp. Company Summary
7.5.2 Conmed Corp. Business Overview
7.5.3 Conmed Corp. Bone and Joint Regenerative Medicines Major Product Offerings
7.5.4 Conmed Corp. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.5.5 Conmed Corp. Key News & Latest Developments
7.6 Depuy Synthes Products Inc.
7.6.1 Depuy Synthes Products Inc. Company Summary
7.6.2 Depuy Synthes Products Inc. Business Overview
7.6.3 Depuy Synthes Products Inc. Bone and Joint Regenerative Medicines Major Product Offerings
7.6.4 Depuy Synthes Products Inc. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.6.5 Depuy Synthes Products Inc. Key News & Latest Developments
7.7 Medtronic Plc
7.7.1 Medtronic Plc Company Summary
7.7.2 Medtronic Plc Business Overview
7.7.3 Medtronic Plc Bone and Joint Regenerative Medicines Major Product Offerings
7.7.4 Medtronic Plc Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.7.5 Medtronic Plc Key News & Latest Developments
7.8 Royal Biologics
7.8.1 Royal Biologics Company Summary
7.8.2 Royal Biologics Business Overview
7.8.3 Royal Biologics Bone and Joint Regenerative Medicines Major Product Offerings
7.8.4 Royal Biologics Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.8.5 Royal Biologics Key News & Latest Developments
7.9 Seikagaku Corp.
7.9.1 Seikagaku Corp. Company Summary
7.9.2 Seikagaku Corp. Business Overview
7.9.3 Seikagaku Corp. Bone and Joint Regenerative Medicines Major Product Offerings
7.9.4 Seikagaku Corp. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.9.5 Seikagaku Corp. Key News & Latest Developments
7.10 Smith & Nephew Plc
7.10.1 Smith & Nephew Plc Company Summary
7.10.2 Smith & Nephew Plc Business Overview
7.10.3 Smith & Nephew Plc Bone and Joint Regenerative Medicines Major Product Offerings
7.10.4 Smith & Nephew Plc Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.10.5 Smith & Nephew Plc Key News & Latest Developments
7.11 Stryker Corp.
7.11.1 Stryker Corp. Company Summary
7.11.2 Stryker Corp. Business Overview
7.11.3 Stryker Corp. Bone and Joint Regenerative Medicines Major Product Offerings
7.11.4 Stryker Corp. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.11.5 Stryker Corp. Key News & Latest Developments
7.12 Zimmer Biomet Holdings Inc.
7.12.1 Zimmer Biomet Holdings Inc. Company Summary
7.12.2 Zimmer Biomet Holdings Inc. Business Overview
7.12.3 Zimmer Biomet Holdings Inc. Bone and Joint Regenerative Medicines Major Product Offerings
7.12.4 Zimmer Biomet Holdings Inc. Bone and Joint Regenerative Medicines Revenue in Global Market (2018-2023）
7.12.5 Zimmer Biomet Holdings Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
